miércoles, 4 de enero de 2017

Reliability of 30-Day Readmission Measures Used in the Hospital Readmission Reduction Program. - PubMed - NCBI

Reliability of 30-Day Readmission Measures Used in the Hospital Readmission Reduction Program. - PubMed - NCBI

 2016 Dec;51(6):2095-2114. doi: 10.1111/1475-6773.12587. Epub 2016 Oct 21.

Reliability of 30-Day Readmission Measures Used in the Hospital Readmission Reduction Program.

Abstract

OBJECTIVE:

To assess the reliability of risk-standardized readmission rates (RSRRs) for medical conditions and surgical procedures used in the Hospital Readmission Reduction Program (HRRP).

DATA SOURCES:

State Inpatient Databases for six states from 2011 to 2013 were used to identify patient cohorts for the six conditions used in the HRRP, which was augmented with hospital characteristic and HRRP penalty data.

STUDY DESIGN:

Hierarchical logistic regression models estimated hospital-level RSRRs for each condition, the reliability of each RSRR, and the extent to which socioeconomic and hospital factors further explain RSRR variation. We used publicly available data to estimate payments for excess readmissions in hospitals with reliable and unreliable RSRRs.

PRINCIPAL FINDINGS:

Only RSRRs for surgical procedures exceeded the reliability benchmark for most hospitals, whereas RSRRs for medical conditions were typically below the benchmark. Additional adjustment for socioeconomic and hospital factors modestly explained variation in RSRRs. Approximately 25 percent of payments for excess readmissions were tied to unreliable RSRRs.

CONCLUSIONS:

Many of the RSRRs employed by the HRRP are unreliable, and one quarter of payments for excess readmissions are associated with unreliable RSRRs. Unreliable measures blur the connection between hospital performance and incentives, and threaten the success of the HRRP.

KEYWORDS:

Readmissions; reliability; risk-adjustment
PMID:
 
27766634
 
PMCID:
 
PMC5134200
 [Available on 2017-12-01]
 
DOI:
 
10.1111/1475-6773.12587
[PubMed - in process]

No hay comentarios: